Press Releases
Quaker Chemical Announces Third Quarter 2013 Results
(Logo: http://photos.prnewswire.com/prnh/20120910/PH70044LOGO )
Mr. Barry continued, "In the fourth quarter, we expect to continue to produce good operating results, subject to typical negative seasonality impacts around the holidays at year end. In summary, I remain confident in our future and I expect 2013 to be another strong year for Quaker in terms of earnings, cash flow generation, EBITDA growth and shareholder value creation."
Third Quarter of 2013 Summary
Net sales for the third quarter of 2013 of
Gross profit increased approximately
Selling, general and administrative expenses ("SG&A") increased
The increase in other expense in the third quarter of 2013 was primarily driven by foreign exchange transaction losses of approximately
The decrease in interest expense was primarily due to lower average borrowings and lower interest rates experienced in the third quarter of 2013 as compared to the third quarter of 2012.
The increase in equity in net income of associated companies from the third quarter of 2012 was primarily due to higher earnings related to the Company's equity interest in a captive insurance company. Earnings from this affiliate were
The Company's effective tax rates for the third quarters of 2013 and 2012 were 33.8% and 28.6%, respectively. The primary contributor to the higher effective tax rate in the current quarter was an increase in
Year-to-Date Summary
Net sales for the first nine months of 2013 of
Gross profit increased by approximately
SG&A increased approximately
Other income for the first nine months of 2013 was
Interest expense was lower in the first nine months of 2013 compared to the first nine months of 2012 primarily due to lower interest rates and lower average borrowings.
The Company's effective tax rates for the first nine months of 2013 and 2012 were 30.0% and 26.9%, respectively. The primary contributor to the higher effective tax rate in the current year was an increase in
Equity in net income of associated companies increased due to higher earnings related to the Company's equity interest in a captive insurance company in the first nine months of 2013 compared to the first nine months of 2012. Earnings attributable to this equity interest increased from approximately
Balance Sheet and Cash Flow Items
The Company's net operating cash flow for the third quarter of 2013 was
Non-GAAP Measures
Included in this public release is a non-GAAP financial measure of non-GAAP earnings per diluted share. The Company believes this non-GAAP financial measure provides meaningful supplemental information as it enhances a reader's understanding of the financial performance of the Company, is more indicative of future operating performance of the Company, and facilitates a better comparison among fiscal periods, as the non-GAAP financial measure excludes items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. The following is a reconciliation between the non-GAAP (unaudited) financial measure of non-GAAP earnings per diluted share to its most directly comparable GAAP (unaudited) financial measure:
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||
2013 |
2012 |
2013 |
2012 |
|||||
GAAP earnings per diluted share attributable to Quaker Chemical Corporation Common Shareholders |
$ 0.95 |
$ 0.83 |
$ 3.21 |
$ 2.63 |
||||
CFO transition costs per diluted share |
— |
— |
— |
0.03 |
||||
Customer bankruptcy costs per diluted share |
— |
— |
— |
0.06 |
||||
Mineral oil excise tax refund per diluted share |
— |
— |
(0.14) |
— |
||||
Change in acquisition-related earnout liability per diluted share |
— |
— |
0.03 |
— |
||||
Cost streamlining initiatives per diluted share |
0.05 |
— |
0.07 |
— |
||||
Devaluation of the Venezuelan Bolivar Fuerte per diluted share |
— |
— |
0.03 |
— |
||||
Equity income in a captive insurance company per diluted share |
(0.09) |
(0.03) |
(0.33) |
(0.11) |
||||
Non-GAAP earnings per diluted share |
$ 0.91 |
$ 0.80 |
$ 2.87 |
$ 2.61 |
Recent Developments
For the third quarter of 2013, the Company expected to receive recertification of a prior concessionary tax rate in
Forward-Looking Statements
This release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
||||||||
Condensed Consolidated Statement of Income |
||||||||
(Dollars in thousands, except per share data) |
||||||||
(Unaudited) |
||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||
2013 |
2012 |
2013 |
2012 |
|||||
Net sales |
$ 184,059 |
$ 180,923 |
$ 545,098 |
$ 535,358 |
||||
Cost of goods sold |
118,069 |
121,797 |
349,186 |
355,801 |
||||
Gross profit |
65,990 |
59,126 |
195,912 |
179,557 |
||||
% |
35.9% |
32.7% |
35.9% |
33.5% |
||||
Selling, general and administrative expenses |
47,183 |
43,263 |
139,901 |
130,009 |
||||
Operating income |
18,807 |
15,863 |
56,011 |
49,548 |
||||
% |
10.2% |
8.8% |
10.3% |
9.3% |
||||
Other (expense) income, net |
(685) |
322 |
1,962 |
529 |
||||
Interest expense |
(717) |
(1,034) |
(2,223) |
(3,359) |
||||
Interest income |
267 |
149 |
665 |
409 |
||||
Income before taxes and equity in net income of associated companies |
17,672 |
15,300 |
56,415 |
47,127 |
||||
Taxes on income before equity in net income of associated companies |
5,972 |
4,373 |
16,933 |
12,692 |
||||
Income before equity in net income of associated companies |
11,700 |
10,927 |
39,482 |
34,435 |
||||
Equity in net income of associated companies |
1,605 |
696 |
4,689 |
2,038 |
||||
Net income |
13,305 |
11,623 |
44,171 |
36,473 |
||||
Less: Net income attributable to noncontrolling interest |
754 |
698 |
1,918 |
2,075 |
||||
Net income attributable to Quaker Chemical Corporation |
$ 12,551 |
$ 10,925 |
$ 42,253 |
$ 34,398 |
||||
% |
6.8% |
6.0% |
7.8% |
6.4% |
||||
Per share data: |
||||||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic |
$ 0.95 |
$ 0.84 |
$ 3.21 |
$ 2.65 |
||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted |
$ 0.95 |
$ 0.83 |
$ 3.21 |
$ 2.63 |
Quaker Chemical Corporation |
||||
Condensed Consolidated Balance Sheet |
||||
(Dollars in thousands, except par value and share amounts) |
||||
(Unaudited) |
||||
September 30, |
December 31, |
|||
2013 |
2012 |
|||
ASSETS |
||||
Current assets |
||||
Cash and cash equivalents |
$ 53,945 |
$ 32,547 |
||
Accounts receivable, net |
166,584 |
154,197 |
||
Inventories, net |
76,670 |
72,471 |
||
Prepaid expenses and other current assets |
16,870 |
18,595 |
||
Total current assets |
314,069 |
277,810 |
||
Property, plant and equipment, net |
84,268 |
85,112 |
||
Goodwill |
58,511 |
59,169 |
||
Other intangible assets, net |
32,028 |
32,809 |
||
Investments in associated companies |
17,789 |
16,603 |
||
Deferred income taxes |
27,284 |
30,673 |
||
Other assets |
36,038 |
34,458 |
||
Total assets |
$ 569,987 |
$ 536,634 |
||
LIABILITIES AND EQUITY |
||||
Current liabilities |
||||
Short-term borrowings and current portion of long-term debt |
$ 1,432 |
$ 1,468 |
||
Accounts and other payables |
81,289 |
70,794 |
||
Accrued compensation |
17,027 |
16,842 |
||
Other current liabilities |
27,399 |
18,688 |
||
Total current liabilities |
127,147 |
107,792 |
||
Long-term debt |
17,765 |
30,000 |
||
Deferred income taxes |
6,127 |
6,383 |
||
Other non-current liabilities |
94,105 |
102,783 |
||
Total liabilities |
245,144 |
246,958 |
||
Equity |
||||
Common stock, $1 par value; authorized 30,000,000 shares; issued 13,187,320 shares |
13,187 |
13,095 |
||
Capital in excess of par value |
97,816 |
94,470 |
||
Retained earnings |
247,833 |
215,390 |
||
Accumulated other comprehensive loss |
(43,238) |
(41,855) |
||
Total Quaker shareholders' equity |
315,598 |
281,100 |
||
Noncontrolling interest |
9,245 |
8,576 |
||
Total equity |
324,843 |
289,676 |
||
Total liabilities and equity |
$ 569,987 |
$ 536,634 |
||
Quaker Chemical Corporation |
||||
Condensed Consolidated Statement of Cash Flows |
||||
For the nine months ended September 30, |
||||
(Dollars in thousands) |
||||
(Unaudited) |
||||
2013 |
2012 |
|||
Cash flows from operating activities |
||||
Net income |
$ 44,171 |
$ 36,473 |
||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation |
9,219 |
9,001 |
||
Amortization |
2,621 |
2,283 |
||
Equity in undistributed earnings of associated companies, net of dividends |
(2,525) |
(1,854) |
||
Deferred compensation and other, net |
(50) |
1,848 |
||
Stock-based compensation |
3,133 |
2,954 |
||
Loss (gain) on disposal of property, plant and equipment |
193 |
(75) |
||
Insurance settlement realized |
(731) |
(1,074) |
||
Pension and other postretirement benefits |
(561) |
(1,823) |
||
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions: |
||||
Accounts receivable |
(13,222) |
(1,381) |
||
Inventories |
(4,569) |
(875) |
||
Prepaid expenses and other current assets |
1,017 |
(1,976) |
||
Accounts payable and accrued liabilities |
13,256 |
(1,731) |
||
Net cash provided by operating activities |
51,952 |
41,770 |
||
Cash flows from investing activities |
||||
Capital expenditures |
(7,330) |
(8,757) |
||
Payments related to acquisitions , net of cash acquired |
(2,478) |
(2,635) |
||
Proceeds from disposition of assets |
391 |
193 |
||
Insurance settlement interest earned |
40 |
53 |
||
Change in restricted cash, net |
691 |
1,021 |
||
Net cash used in investing activities |
(8,686) |
(10,125) |
||
Cash flows from financing activities |
||||
Repayments of long-term debt |
(12,289) |
(9,672) |
||
Dividends paid |
(9,721) |
(9,410) |
||
Stock options exercised, other |
(510) |
(828) |
||
Excess tax benefit related to stock option exercises |
815 |
2,164 |
||
Distributions to noncontrolling shareholders |
(30) |
(30) |
||
Net cash used in financing activities |
(21,735) |
(17,776) |
||
Effect of exchange rate changes on cash |
(133) |
(606) |
||
Net increase in cash and cash equivalents |
21,398 |
13,263 |
||
Cash and cash equivalents at the beginning of the period |
32,547 |
16,909 |
||
Cash and cash equivalents at the end of the period |
$ 53,945 |
$ 30,172 |
||
SOURCE
Margaret M. Loebl, Vice President, Chief Financial Officer and Treasurer, loeblm@quakerchem.com, T. 610.832.4160